Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program

Contemporary Clinical Trials

Volumn 33, Issue 1, 2012, Pages 46-54

  Carpenter, William R ^a,b,c   Fortune Greeley, Alice K ^a   Zullig, Leah L ^a   Lee, Shoou Yih ^d   Weiner, Bryan J ^a,b,c  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cancer; Clinical research; Community Clinical Oncology Program; Environment and public health; Practice based research networks

Indexed keywords

ARTICLE; CLINICAL RESEARCH; ENVIRONMENTAL FACTOR; HEALTH PROGRAM; QUASI EXPERIMENTAL STUDY;

COMMUNITY HEALTH SERVICES; HUMANS; MEDICAL ONCOLOGY; NATIONAL CANCER INSTITUTE (U.S.); NATIONAL HEALTH PROGRAMS; NEOPLASMS; ORGANIZATIONAL AFFILIATION; PROGRAM EVALUATION; RESEARCH DESIGN; UNITED STATES;

EID: 84855379571     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.09.007     Document Type: Article

References (26)

1. Minasian L.M., Carpenter W.R., Weiner B.J., et al. Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer 2010, 116(19):4440-4449.
2. National Cancer Institute Special issue: clinical trials enrollment. NCI Cancer Bull 2010, 7(10).
3. Institute of Medicine A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program 2010, Washington DC, Prepublication Copy.
4. National Cancer Institute Report of the Operational Efficiency Working Group Clinical Trials and Translational Research Advisory Committee 2010, DHHS, Bethesda, MD.
5. ASCO Cancer trial accrual symposium April 29-30, 2010, Bethesda, MD. http://university.asco.org/CT2010.
6. Printz C. NCI, cooperative groups gear up for changes in clinical trials system: new policies initiated in response to institute of medicine report. Cancer 2011, 117(10):2017-2019.
7. Carpenter W.R., Weiner B.J., Kaluzny A.D., Domino M.E., Lee S.Y. The effects of managed care and competition on community-based clinical research. Med Care Jul 2006, 44(7):671-679.
8. McKinney M.M., Weiner B.J., Carpenter W.R. Building community capacity to participate in cancer prevention research. Cancer Control Oct 2006, 13(4):295-302.
9. Weiner B.J., McKinney M.M., Carpenter W.R. Adapting clinical trials networks to promote cancer prevention and control research. Cancer 2006, 106(1):180-187.
10. Elliott S.P., Jarosek S.L., Wilt T.J., Virnig B.A. Reduction in physician reimbursement and use of hormone therapy in prostate cancer. J Natl Cancer Inst 2010, 102(24):1826-1834.
11. Weight C.J., Klein E.A., Jones J.S. Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population. Cancer May 15 2008, 112(10):2195-2201.
12. Friedman J.Y., Curtis L.H., Hammill B.G., et al. The Medicare Modernization Act and reimbursement for outpatient chemotherapy: do patients perceive changes in access to care?. Cancer 2007, 110(10):2304-2312.
13. Edge S.B., Zwelling L.A., Hohn D.C. The anticipated and unintended consequences of the patient protection and affordable care act on cancer research. Cancer J Nov-Dec 2010, 16(6):606-613.
14. Albright H.W., Moreno M., Feeley T.W., et al. The implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on cancer care delivery. Cancer 2011, 117(8):1564-1574.
15. National Cancer Institute - Division of Cancer Prevention. Community Clinical Oncology Program (CCOP) Accessed June 20, 2011. http://prevention.cancer.gov/programs-resources/programs/ccop.
16. Warnecke R.B., Johnson T.P., Kaluzny A.D., Ford L.G. The community clinical oncology program: its effect on clinical practice. Jt Comm J Qual Improv Jul 1995, 21(7):336-339.
17. Laliberte L., Fennell M.L., Papandonatos G. The relationship of membership in research networks to compliance with treatment guidelines for early-stage breast cancer. Med Care 2005, 43(5):471.
18. Carpenter W., Reeder-Hayes K., Bainbridge J., et al. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care 2011, 49(2):172-179.
19. Yitzhaki S. On an extension of the Gini inequality index. Int. Econ. Rev. 1983, 24(3):617-628.
20. Interstudy. Competitive Edge Database. Excelsior MN2000-2006, 2009.
21. Baker L. Measuring competition in health care markets. Health Serv Res 2001, 36(10):223-251.
22. Murthy V., Krumholz H., Gross C. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004, 291(22):2720.
23. Wooldridge J.M. Introductory econometrics: a modern approach 2009, South-Western College Publishing. 4th ed.
24. Hausman J.A. Specification tests in econometrics. Econometrica J. Econ. Soc. 1978, 46(6):1251-1271.
25. Kaluzny A.D., Lacey L.M., Warnecke R., et al. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program. Health Serv Res Jun 1993, 28(2):159-182.
26. Kaluzny A.D., Ricketts T., Warnecke R., et al. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program. J Natl Cancer Inst 1989, 81(22):1717-1725.